{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:11:00Z","timestamp":1790640660409,"version":"4.1.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,16]],"date-time":"2014-09-16T00:00:00Z","timestamp":1410825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12974-014-0162-y","type":"journal-article","created":{"date-parts":[[2014,9,15]],"date-time":"2014-09-15T14:42:52Z","timestamp":1410792172000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function"],"prefix":"10.1186","volume":"11","author":[{"given":"Anusha","family":"Jayaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Lent-Schochet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J","family":"Pike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,16]]},"reference":[{"key":"162_CR1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-5122(00)00192-4","volume":"38","author":"JE Morley","year":"2001","unstructured":"Morley JE: Androgens and aging. Maturitas. 2001, 38: 61-71. Discussion 71-73","journal-title":"Maturitas"},{"key":"162_CR2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","volume":"26","author":"JM Kaufman","year":"2005","unstructured":"Kaufman JM, Vermeulen A: The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005, 26: 833-876.","journal-title":"Endocr Rev"},{"key":"162_CR3","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.maturitas.2011.05.012","volume":"69","author":"J Holland","year":"2011","unstructured":"Holland J, Bandelow S, Hogervorst E: Testosterone levels and cognition in elderly men: a review. Maturitas. 2011, 69: 322-337.","journal-title":"Maturitas"},{"key":"162_CR4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.neuroscience.2005.09.007","volume":"138","author":"JS Janowsky","year":"2006","unstructured":"Janowsky JS: The role of androgens in cognition and brain aging in men. Neuroscience. 2006, 138: 1015-1020.","journal-title":"Neuroscience"},{"key":"162_CR5","doi-asserted-by":"crossref","first-page":"13384","DOI":"10.1523\/JNEUROSCI.2514-06.2006","volume":"26","author":"ER Rosario","year":"2006","unstructured":"Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ: Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer\u2019s disease. J Neurosci. 2006, 26: 13384-13389.","journal-title":"J Neurosci"},{"key":"162_CR6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1101\/lm.1428209","volume":"16","author":"TS Benice","year":"2009","unstructured":"Benice TS, Raber J: Testosterone and dihydrotestosterone differentially improve cognition in aged female mice. Learn Mem. 2009, 16: 479-485.","journal-title":"Learn Mem"},{"key":"162_CR7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1523\/JNEUROSCI.4516-03.2004","volume":"24","author":"C Leranth","year":"2004","unstructured":"Leranth C, Hajszan T, MacLusky NJ: Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci. 2004, 24: 495-499.","journal-title":"J Neurosci"},{"key":"162_CR8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0006-8993(01)03024-4","volume":"919","author":"CJ Pike","year":"2001","unstructured":"Pike CJ: Testosterone attenuates beta-amyloid toxicity in cultured hippocampal neurons. Brain Res. 2001, 919: 160-165.","journal-title":"Brain Res"},{"key":"162_CR9","first-page":"515","volume":"30","author":"S Gadau","year":"2009","unstructured":"Gadau S, Lepore G, Zedda M, Mura A, Farina V: Different nitrosative-induced microtubular modifications and testosterone neuroprotective effects on high-D-glucose-exposed neuroblastoma and glioma cells. Neuro Endocrinol Lett. 2009, 30: 515-524.","journal-title":"Neuro Endocrinol Lett"},{"key":"162_CR10","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1212\/WNL.62.2.188","volume":"62","author":"SD Moffat","year":"2004","unstructured":"Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM: Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004, 62: 188-193.","journal-title":"Neurology"},{"key":"162_CR11","first-page":"163","volume":"22","author":"E Hogervorst","year":"2001","unstructured":"Hogervorst E, Williams J, Budge M, Barnetson L, Combrinck M, Smith AD: Serum total testosterone is lower in men with Alzheimer\u2019s disease. Neuro Endocrinol Lett. 2001, 22: 163-168.","journal-title":"Neuro Endocrinol Lett"},{"key":"162_CR12","first-page":"203","volume":"24","author":"E Hogervorst","year":"2003","unstructured":"Hogervorst E, Combrinck M, Smith AD: Testosterone and gonadotropin levels in men with dementia. Neuro Endocrinol Lett. 2003, 24: 203-208.","journal-title":"Neuro Endocrinol Lett"},{"key":"162_CR13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/01.WNL.0000094199.60829.F5","volume":"62","author":"AM Paoletti","year":"2004","unstructured":"Paoletti AM, Congia S, Lello S, Tedde D, Orru M, Pistis M, Pilloni M, Zedda P, Loddo A, Melis GB: Low androgenization index in elderly women and elderly men with Alzheimer\u2019s disease. Neurology. 2004, 62: 301-303.","journal-title":"Neurology"},{"key":"162_CR14","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jama.292.12.1431-b","volume":"292","author":"ER Rosario","year":"2004","unstructured":"Rosario ER, Chang L, Stanczyk FZ, Pike CJ: Age-related testosterone depletion and the development of Alzheimer disease. JAMA. 2004, 292: 1431-1432.","journal-title":"JAMA"},{"key":"162_CR15","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.neurobiolaging.2009.04.008","volume":"32","author":"ER Rosario","year":"2011","unstructured":"Rosario ER, Chang L, Head EH, Stanczyk FZ, Pike CJ: Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer\u2019s disease. Neurobiol Aging. 2011, 32: 604-613.","journal-title":"Neurobiol Aging"},{"key":"162_CR16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1007105121765","volume":"29","author":"RC Melcangi","year":"2000","unstructured":"Melcangi RC, Magnaghi V, Galbiati M, Ghelarducci B, Sebastiani L, Martini L: The action of steroid hormones on peripheral myelin proteins: a possible new tool for the rebuilding of myelin?. J Neurocytol. 2000, 29: 327-339.","journal-title":"J Neurocytol"},{"key":"162_CR17","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00018-007-7002-5","volume":"64","author":"I Roglio","year":"2007","unstructured":"Roglio I, Bianchi R, Giatti S, Cavaletti G, Caruso D, Scurati S, Crippa D, Garcia-Segura LM, Camozzi F, Lauria G, Melcangi RC: Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol Life Sci. 2007, 64: 1158-1168.","journal-title":"Cell Mol Life Sci"},{"key":"162_CR18","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1111\/j.1743-6109.2010.01705.x","volume":"7","author":"A Hernandez-Mijares","year":"2010","unstructured":"Hernandez-Mijares A, Garcia-Malpartida K, Sola-Izquierdo E, Banuls C, Rocha M, Gomez-Martinez MJ, Marmol R, Victor VM: Testosterone levels in males with type 2 diabetes and their relationship with cardiovascular risk factors and cardiovascular disease. J Sex Med. 2010, 7: 1954-1964.","journal-title":"J Sex Med"},{"key":"162_CR19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1159\/000341193","volume":"5","author":"EM Mathus-Vliegen","year":"2012","unstructured":"Mathus-Vliegen EM: Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline. Obes Facts. 2012, 5: 460-483.","journal-title":"Obes Facts"},{"key":"162_CR20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/archinte.163.4.395","volume":"163","author":"JO Hill","year":"2003","unstructured":"Hill JO, Bessesen D: What to do about the metabolic syndrome?. Arch Intern Med. 2003, 163: 395-397.","journal-title":"Arch Intern Med"},{"key":"162_CR21","doi-asserted-by":"crossref","first-page":"pe19","DOI":"10.1126\/sageke.2006.10.pe19","volume":"2006","author":"JA Luchsinger","year":"2006","unstructured":"Luchsinger JA: A work in progress: the metabolic syndrome. Sci Aging Knowledge Environ. 2006, 2006: pe19.","journal-title":"Sci Aging Knowledge Environ"},{"key":"162_CR22","doi-asserted-by":"crossref","first-page":"139239","DOI":"10.1155\/2013\/139239","volume":"2013","author":"K Makki","year":"2013","unstructured":"Makki K, Froguel P, Wolowczuk I: Adipose tissue in obesity-related inflammation and insulin resistance: cells, cytokines, and chemokines. ISRN Inflamm. 2013, 2013: 139239.","journal-title":"ISRN Inflamm"},{"key":"162_CR23","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/humupd\/dmr017","volume":"17","author":"KJ Teerds","year":"2011","unstructured":"Teerds KJ, de Rooij DG, Keijer J: Functional relationship between obesity and male reproduction: from humans to animal models. Hum Reprod Update. 2011, 17: 667-683.","journal-title":"Hum Reprod Update"},{"key":"162_CR24","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1001\/jama.292.18.2237","volume":"292","author":"K Yaffe","year":"2004","unstructured":"Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA. 2004, 292: 2237-2242.","journal-title":"JAMA"},{"key":"162_CR25","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/archneur.62.10.1556","volume":"62","author":"M Kivipelto","year":"2005","unstructured":"Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kareholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol. 2005, 62: 1556-1560.","journal-title":"Arch Neurol"},{"key":"162_CR26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archneurol.2008.570","volume":"66","author":"AM Kanaya","year":"2009","unstructured":"Kanaya AM, Lindquist K, Harris TB, Launer L, Rosano C, Satterfield S, Yaffe K: Total and regional adiposity and cognitive change in older adults: the health, aging and body composition (ABC) study. Arch Neurol. 2009, 66: 329-335.","journal-title":"Arch Neurol"},{"key":"162_CR27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.66.3.343","volume":"66","author":"EP Helzner","year":"2009","unstructured":"Helzner EP, Luchsinger JA, Scarmeas N, Cosentino S, Brickman AM, Glymour MM, Stern Y: Contribution of vascular risk factors to the progression in Alzheimer disease. Arch Neurol. 2009, 66: 343-348.","journal-title":"Arch Neurol"},{"key":"162_CR28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bcp.2012.05.007","volume":"84","author":"R Williamson","year":"2012","unstructured":"Williamson R, McNeilly A, Sutherland C: Insulin resistance in the brain: an old-age or new-age problem?. Biochem Pharmacol. 2012, 84: 737-745.","journal-title":"Biochem Pharmacol"},{"key":"162_CR29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ana.23986","volume":"74","author":"B Callaghan","year":"2013","unstructured":"Callaghan B, Feldman E: The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol. 2013, 74: 397-403.","journal-title":"Ann Neurol"},{"key":"162_CR30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/dc06-1426","volume":"30","author":"D Kapoor","year":"2007","unstructured":"Kapoor D, Aldred H, Clark S, Channer KS, Jones TH: Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007, 30: 911-917.","journal-title":"Diabetes Care"},{"key":"162_CR31","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1210\/jc.2008-0054","volume":"93","author":"V Kupelian","year":"2008","unstructured":"Kupelian V, Hayes FJ, Link CL, Rosen R, McKinlay JB: Inverse association of testosterone and the metabolic syndrome in men is consistent across race and ethnic groups. J Clin Endocrinol Metab. 2008, 93: 3403-3410.","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/diacare.23.4.490","volume":"23","author":"RK Stellato","year":"2000","unstructured":"Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB: Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000, 23: 490-494.","journal-title":"Diabetes Care"},{"key":"162_CR33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/met.2004.2.39","volume":"2","author":"B Zou","year":"2004","unstructured":"Zou B, Sasaki H, Kumagai S: Association between relative hypogonadism and metabolic syndrome in newly diagnosed adult male patients with impaired glucose tolerance or type 2 diabetes mellitus. Metab Syndr Relat Disord. 2004, 2: 39-48.","journal-title":"Metab Syndr Relat Disord"},{"key":"162_CR34","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jc.2007-2177","volume":"93","author":"M Grossmann","year":"2008","unstructured":"Grossmann M, Thomas MC, Panagiotopoulos S, Sharpe K, Macisaac RJ, Clarke S, Zajac JD, Jerums G: Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008, 93: 1834-1840.","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR35","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2337\/diacare.28.7.1636","volume":"28","author":"N Pitteloud","year":"2005","unstructured":"Pitteloud N, Mootha VK, Dwyer AA, Hardin M, Lee H, Eriksson KF, Tripathy D, Yialamas M, Groop L, Elahi D, Hayes FJ: Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005, 28: 1636-1642.","journal-title":"Diabetes Care"},{"key":"162_CR36","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2337\/dc08-0851","volume":"31","author":"A Chandel","year":"2008","unstructured":"Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P: Testosterone concentration in young patients with diabetes. Diabetes Care. 2008, 31: 2013-2017.","journal-title":"Diabetes Care"},{"key":"162_CR37","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.1210\/jc.2004-0804","volume":"89","author":"S Dhindsa","year":"2004","unstructured":"Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P: Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004, 89: 5462-5468.","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/jc.2007-1291","volume":"93","author":"CA Allan","year":"2008","unstructured":"Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI: Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab. 2008, 93: 139-146.","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR39","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1210\/jc.2006-2060","volume":"92","author":"S Bhasin","year":"2007","unstructured":"Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM: Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity. J Clin Endocrinol Metab. 2007, 92: 1049-1057.","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR40","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.2007-2595","volume":"93","author":"S Shahani","year":"2008","unstructured":"Shahani S, Braga-Basaria M, Basaria S: Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis. J Clin Endocrinol Metab. 2008, 93: 2042-2049.","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/13685530701653538","volume":"10","author":"A Haidar","year":"2007","unstructured":"Haidar A, Yassin A, Saad F, Shabsigh R: Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male. 2007, 10: 189-196.","journal-title":"Aging Male"},{"key":"162_CR42","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","volume":"24","author":"NL Keating","year":"2006","unstructured":"Keating NL, O\u2019Malley AJ, Smith MR: Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. J Clin Oncol. 2006, 24: 4448-4456.","journal-title":"J Clin Oncol"},{"key":"162_CR43","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1200\/JCO.2006.05.9741","volume":"24","author":"M Braga-Basaria","year":"2006","unstructured":"Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, Egan J, Basaria S: Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol. 2006, 24: 3979-3983.","journal-title":"J Clin Oncol"},{"key":"162_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15321819508013546","volume":"16","author":"M Singh","year":"1995","unstructured":"Singh M, Lin SQ, Saxena BB: Effect of immunization with lutropin-receptor on the ovarian function of rabbits. J Immunoassay. 1995, 16: 1-16.","journal-title":"J Immunoassay"},{"key":"162_CR45","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1210\/en.2012-1464","volume":"153","author":"A Jayaraman","year":"2012","unstructured":"Jayaraman A, Carroll JC, Morgan TE, Lin S, Zhao L, Arimoto JM, Murphy MP, Beckett TL, Finch CE, Brinton RD, Pike CJ: 17beta-estradiol and progesterone regulate expression of beta-amyloid clearance factors in primary neuron cultures and female rat brain. Endocrinology. 2012, 153: 5467-5479.","journal-title":"Endocrinology"},{"key":"162_CR46","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408.","journal-title":"Methods"},{"key":"162_CR47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2012.02.056","volume":"1450","author":"R Aras","year":"2012","unstructured":"Aras R, Barron AM, Pike CJ: Caspase activation contributes to astrogliosis. Brain Res. 2012, 1450: 102-115.","journal-title":"Brain Res"},{"key":"162_CR48","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2337\/diab.37.10.1340","volume":"37","author":"R Bianchi","year":"1988","unstructured":"Bianchi R, Marini P, Merlini S, Fabris M, Triban C, Mussini E, Fiori MG: ATPase activity defects in alloxan-induced diabetic sciatic nerve recovered by ganglioside treatment. Diabetes. 1988, 37: 1340-1345.","journal-title":"Diabetes"},{"key":"162_CR49","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.neuroscience.2009.08.005","volume":"164","author":"S Giatti","year":"2009","unstructured":"Giatti S, Pesaresi M, Cavaletti G, Bianchi R, Carozzi V, Lombardi R, Maschi O, Lauria G, Garcia-Segura LM, Caruso D, Melcangi RC: Neuroprotective effects of a ligand of translocator protein-18\u2009kDa (Ro5-4864) in experimental diabetic neuropathy. Neuroscience. 2009, 164: 520-529.","journal-title":"Neuroscience"},{"key":"162_CR50","doi-asserted-by":"crossref","first-page":"865965","DOI":"10.1155\/2013\/865965","volume":"2013","author":"MP Canale","year":"2013","unstructured":"Canale MP, Manca Di Villahermosa S, Martino G, Rovella V, Noce A, De Lorenzo AD, Daniele N: Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity. Int J Endocrinol. 2013, 2013: 865965.","journal-title":"Int J Endocrinol"},{"key":"162_CR51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2165\/00002512-200825050-00001","volume":"25","author":"D Kapoor","year":"2008","unstructured":"Kapoor D, Jones TH: Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention?. Drugs Aging. 2008, 25: 357-369.","journal-title":"Drugs Aging"},{"key":"162_CR52","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1743-6109.2010.01991.x","volume":"8","author":"G Corona","year":"2011","unstructured":"Corona G, Monami M, Rastrelli G, Aversa A, Tishova Y, Saad F, Lenzi A, Forti G, Mannucci E, Maggi M: Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med. 2011, 8: 272-283.","journal-title":"J Sex Med"},{"key":"162_CR53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsbmb.2008.12.022","volume":"114","author":"F Saad","year":"2009","unstructured":"Saad F, Gooren L: The role of testosterone in the metabolic syndrome: a review. J Steroid Biochem Mol Biol. 2009, 114: 40-43.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"162_CR54","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1467-789X.2012.01051.x","volume":"14","author":"AJ Cameron","year":"2013","unstructured":"Cameron AJ, Magliano DJ, Soderberg S: A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev. 2013, 14: 86-94.","journal-title":"Obes Rev"},{"key":"162_CR55","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1463-1326.2011.01536.x","volume":"14","author":"AJ Garber","year":"2012","unstructured":"Garber AJ: Obesity and type 2 diabetes: which patients are at risk?. Diabetes Obes Metab. 2012, 14: 399-408.","journal-title":"Diabetes Obes Metab"},{"key":"162_CR56","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000176046","volume":"37","author":"RD Stanworth","year":"2009","unstructured":"Stanworth RD, Jones TH: Testosterone in obesity, metabolic syndrome and type 2 diabetes. Front Horm Res. 2009, 37: 74-90.","journal-title":"Front Horm Res"},{"key":"162_CR57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MED.0b013e32833919cf","volume":"17","author":"M Grossmann","year":"2010","unstructured":"Grossmann M, Gianatti EJ, Zajac JD: Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010, 17: 247-256.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"162_CR58","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuroscience.2013.08.044","volume":"253","author":"TL Davidson","year":"2013","unstructured":"Davidson TL, Hargrave SL, Swithers SE, Sample CH, Fu X, Kinzig KP, Zheng W: Inter-relationships among diet, obesity and hippocampal-dependent cognitive function. Neuroscience. 2013, 253: 110-122.","journal-title":"Neuroscience"},{"key":"162_CR59","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3233\/JAD-121885","volume":"34","author":"L Feng","year":"2013","unstructured":"Feng L, Chong MS, Lim WS, Lee TS, Collinson SL, Yap P, Ng TP: Metabolic syndrome and amnestic mild cognitive impairment: Singapore longitudinal ageing study-2 findings. J Alzheimers Dis. 2013, 34: 649-657.","journal-title":"J Alzheimers Dis"},{"key":"162_CR60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12603-012-0002-7","volume":"16","author":"M Maggio","year":"2012","unstructured":"Maggio M, Dall\u2019Aglio E, Lauretani F, Cattabiani C, Ceresini G, Caffarra P, Valenti G, Volpi R, Vignali A, Schiavi G, Ceda GP: The hormonal pathway to cognitive impairment in older men. J Nutr Health Aging. 2012, 16: 40-54.","journal-title":"J Nutr Health Aging"},{"key":"162_CR61","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/eje.1.02306","volume":"155","author":"O Beauchet","year":"2006","unstructured":"Beauchet O: Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol. 2006, 155: 773-781.","journal-title":"Eur J Endocrinol"},{"key":"162_CR62","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrendo.2009.212","volume":"5","author":"M Zitzmann","year":"2009","unstructured":"Zitzmann M: Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009, 5: 673-681.","journal-title":"Nat Rev Endocrinol"},{"key":"162_CR63","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.fob.2013.09.002","volume":"3","author":"G Castro","year":"2013","unstructured":"Castro G, MF CA, Weissmann L, Quaresma PG, Katashima CK, Saad MJ, Prada PO: Diet-induced obesity induces endoplasmic reticulum stress and insulin resistance in the amygdala of rats. FEBS Open Bio. 2013, 3: 443-449.","journal-title":"FEBS Open Bio"},{"key":"162_CR64","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/HYPERTENSIONAHA.111.180943","volume":"59","author":"DD Davis","year":"2012","unstructured":"Davis DD, Ruiz AL, Yanes LL, Iliescu R, Yuan K, Moulana M, Racusen LC, Reckelhoff JF: Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure. Hypertension. 2012, 59: 726-731.","journal-title":"Hypertension"},{"key":"162_CR65","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/oxfordjournals.aje.a008832","volume":"143","author":"SM Haffner","year":"1996","unstructured":"Haffner SM, Shaten J, Stern MP, Smith GD, Kuller L: Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996, 143: 889-897.","journal-title":"Am J Epidemiol"},{"key":"162_CR66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1439-0272.2008.00863.x","volume":"41","author":"NP Goncharov","year":"2009","unstructured":"Goncharov NP, Katsya GV, Chagina NA, Gooren LJ: Testosterone and obesity in men under the age of 40\u2009years. Andrologia. 2009, 41: 76-83.","journal-title":"Andrologia"},{"key":"162_CR67","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1210\/jc.2004-0784","volume":"89","author":"ET Schroeder","year":"2004","unstructured":"Schroeder ET, Zheng L, Ong MD, Martinez C, Flores C, Stewart Y, Azen C, Sattler FR: Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab. 2004, 89: 4863-4872.","journal-title":"J Clin Endocrinol Metab"},{"key":"162_CR68","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","volume":"154","author":"D Kapoor","year":"2006","unstructured":"Kapoor D, Goodwin E, Channer KS, Jones TH: Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006, 154: 899-906.","journal-title":"Eur J Endocrinol"},{"key":"162_CR69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/tam.6.1.1.7","volume":"6","author":"MA Boyanov","year":"2003","unstructured":"Boyanov MA, Boneva Z, Christov VG: Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003, 6: 1-7.","journal-title":"Aging Male"},{"key":"162_CR70","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS: Inflammation and metabolic disorders. Nature. 2006, 444: 860-867.","journal-title":"Nature"},{"key":"162_CR71","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","volume":"353","author":"MI Schmidt","year":"1999","unstructured":"Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G: Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999, 353: 1649-1652.","journal-title":"Lancet"},{"key":"162_CR72","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011, 11: 98-107.","journal-title":"Nat Rev Immunol"},{"key":"162_CR73","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbi.2013.06.007","volume":"35","author":"LB Buckman","year":"2014","unstructured":"Buckman LB, Hasty AH, Flaherty DK, Buckman CT, Thompson MM, Matlock BK, Weller K, Ellacott KL: Obesity induced by a high-fat diet is associated with increased immune cell entry into the central nervous system. Brain Behav Immun. 2014, 35: 33-42.","journal-title":"Brain Behav Immun"},{"key":"162_CR74","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.tem.2012.11.003","volume":"24","author":"D Cai","year":"2013","unstructured":"Cai D: Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol Metab. 2013, 24: 40-47.","journal-title":"Trends Endocrinol Metab"},{"key":"162_CR75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2012.01.061","volume":"1446","author":"A Fung","year":"2012","unstructured":"Fung A, Vizcaychipi M, Lloyd D, Wan Y, Ma D: Central nervous system inflammation in disease related conditions: mechanistic prospects. Brain Res. 2012, 1446: 144-155.","journal-title":"Brain Res"},{"key":"162_CR76","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.4161\/cc.8.16.9386","volume":"8","author":"D Cai","year":"2009","unstructured":"Cai D: NFkappaB-mediated metabolic inflammation in peripheral tissues versus central nervous system. Cell Cycle. 2009, 8: 2542-2548.","journal-title":"Cell Cycle"},{"key":"162_CR77","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1084\/jem.169.6.2227","volume":"169","author":"M Rampart","year":"1989","unstructured":"Rampart M, De Smet W, Fiers W, Herman AG: Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo. J Exp Med. 1989, 169: 2227-2232.","journal-title":"J Exp Med"},{"key":"162_CR78","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1359-6101(97)00023-3","volume":"8","author":"CA Dinarello","year":"1997","unstructured":"Dinarello CA: Interleukin-1. Cytokine Growth Factor Rev. 1997, 8: 253-265.","journal-title":"Cytokine Growth Factor Rev"},{"key":"162_CR79","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1248\/bpb.34.1724","volume":"34","author":"J Xu","year":"2011","unstructured":"Xu J, Itoh Y, Hayashi H, Takii T, Miyazawa K, Onozaki K: Dihydrotestosterone inhibits interleukin-1alpha or tumor necrosis factor alpha-induced proinflammatory cytokine production via androgen receptor-dependent inhibition of nuclear factor-kappaB activation in rheumatoid fibroblast-like synovial cell line. Biol Pharm Bull. 2011, 34: 1724-1730.","journal-title":"Biol Pharm Bull"},{"key":"162_CR80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0006-8993(00)03155-3","volume":"892","author":"E Ahlbom","year":"2001","unstructured":"Ahlbom E, Prins GS, Ceccatelli S: Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 2001, 892: 255-262.","journal-title":"Brain Res"},{"key":"162_CR81","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1471-4159.2005.03318.x","volume":"94","author":"TV Nguyen","year":"2005","unstructured":"Nguyen TV, Yao M, Pike CJ: Androgens activate mitogen-activated protein kinase signaling: role in neuroprotection. J Neurochem. 2005, 94: 1639-1651.","journal-title":"J Neurochem"},{"key":"162_CR82","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jne.12007","volume":"25","author":"E De Marinis","year":"2013","unstructured":"De Marinis E, Acaz-Fonseca E, Arevalo MA, Ascenzi P, Fiocchetti M, Marino M, Garcia-Segura LM: 17beta-Oestradiol anti-inflammatory effects in primary astrocytes require oestrogen receptor beta-mediated neuroglobin up-regulation. J Neuroendocrinol. 2013, 25: 260-270.","journal-title":"J Neuroendocrinol"},{"key":"162_CR83","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/neu.1038","volume":"47","author":"I Azcoitia","year":"2001","unstructured":"Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM: Brain aromatase is neuroprotective. J Neurobiol. 2001, 47: 318-329.","journal-title":"J Neurobiol"},{"key":"162_CR84","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuint.2003.09.007","volume":"45","author":"T Nakagawa","year":"2004","unstructured":"Nakagawa T, Schwartz JP: Gene expression patterns in in vivo normal adult astrocytes compared with cultured neonatal and normal adult astrocytes. Neurochem Int. 2004, 45: 203-242.","journal-title":"Neurochem Int"},{"key":"162_CR85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0197-4580(97)00169-3","volume":"19","author":"I Rozovsky","year":"1998","unstructured":"Rozovsky I, Finch CE, Morgan TE: Age-related activation of microglia and astrocytes: in vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging. 1998, 19: 97-103.","journal-title":"Neurobiol Aging"},{"key":"162_CR86","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1006\/exnr.1998.6801","volume":"151","author":"JR Day","year":"1998","unstructured":"Day JR, Frank AT, O\u2019Callaghan JP, Jones BC, Anderson JE: The effect of age and testosterone on the expression of glial fibrillary acidic protein in the rat cerebellum. Exp Neurol. 1998, 151: 343-346.","journal-title":"Exp Neurol"},{"key":"162_CR87","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1046\/j.1471-4159.1999.721552.x","volume":"72","author":"CJ Pike","year":"1999","unstructured":"Pike CJ: Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer\u2019s disease. J Neurochem. 1999, 72: 1552-1563.","journal-title":"J Neurochem"},{"key":"162_CR88","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1523\/JNEUROSCI.23-05-01588.2003","volume":"23","author":"C Leranth","year":"2003","unstructured":"Leranth C, Petnehazy O, MacLusky NJ: Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci. 2003, 23: 1588-1592.","journal-title":"J Neurosci"},{"key":"162_CR89","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1677\/joe.0.1170229","volume":"117","author":"RH Lustig","year":"1988","unstructured":"Lustig RH, Pfaff DW, Fishman J: Induction of LH hypersecretion in cyclic rats during the afternoon of oestrus by oestrogen in conjunction with progesterone antagonism or opioidergic blockade. J Endocrinol. 1988, 117: 229-235.","journal-title":"J Endocrinol"},{"key":"162_CR90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jnr.22748","volume":"90","author":"BM Barth","year":"2012","unstructured":"Barth BM, Gustafson SJ, Kuhn TB: Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-alpha. J Neurosci Res. 2012, 90: 229-242.","journal-title":"J Neurosci Res"},{"key":"162_CR91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2004.01.009","volume":"187","author":"G Wong","year":"2004","unstructured":"Wong G, Goldshmit Y, Turnley AM: Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp Neurol. 2004, 187: 171-177.","journal-title":"Exp Neurol"},{"key":"162_CR92","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1523\/JNEUROSCI.22-03-00854.2002","volume":"22","author":"H Neumann","year":"2002","unstructured":"Neumann H, Schweigreiter R, Yamashita T, Rosenkranz K, Wekerle H, Barde YA: Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J Neurosci. 2002, 22: 854-862.","journal-title":"J Neurosci"},{"key":"162_CR93","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11481-012-9342-7","volume":"7","author":"A Mishra","year":"2012","unstructured":"Mishra A, Kim HJ, Shin AH, Thayer SA: Synapse loss induced by interleukin-1beta requires pre- and post-synaptic mechanisms. J Neuroimmune Pharmacol. 2012, 7: 571-578.","journal-title":"J Neuroimmune Pharmacol"},{"key":"162_CR94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2012.10.025","volume":"1490","author":"K Zhang","year":"2013","unstructured":"Zhang K, Xu H, Cao L, Li K, Huang Q: Interleukin-1beta inhibits the differentiation of hippocampal neural precursor cells into serotonergic neurons. Brain Res. 2013, 1490: 193-201.","journal-title":"Brain Res"},{"key":"162_CR95","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.nurt.2009.07.004","volume":"6","author":"IG Obrosova","year":"2009","unstructured":"Obrosova IG: Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics. 2009, 6: 638-647.","journal-title":"Neurotherapeutics"},{"key":"162_CR96","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/BF00968712","volume":"19","author":"CL Rowe-Rendleman","year":"1994","unstructured":"Rowe-Rendleman CL, Eichberg J: P0 phosphorylation in nerves from normal and diabetic rats: role of protein kinase C and turnover of phosphate groups. Neurochem Res. 1994, 19: 1023-1031.","journal-title":"Neurochem Res"},{"key":"162_CR97","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0022-510X(93)90268-4","volume":"120","author":"E Scarpini","year":"1993","unstructured":"Scarpini E, Bianchi R, Moggio M, Sciacco M, Fiori MG, Scarlato G: Decrease of nerve Na+, K(+)-ATPase activity in the pathogenesis of human diabetic neuropathy. J Neurol Sci. 1993, 120: 159-167.","journal-title":"J Neurol Sci"},{"key":"162_CR98","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2337\/diacare.19.6.564","volume":"19","author":"D Raccah","year":"1996","unstructured":"Raccah D, Fabreguetts C, Azulay JP, Vague P: Erythrocyte Na(+)-K(+)-ATPase activity, metabolic control, and neuropathy in IDDM patients. Diabetes Care. 1996, 19: 564-568.","journal-title":"Diabetes Care"},{"key":"162_CR99","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/BF00277324","volume":"30","author":"L Wuarin-Bierman","year":"1987","unstructured":"Wuarin-Bierman L, Zahnd GR, Kaufmann F, Burcklen L, Adler J: Hyperalgesia in spontaneous and experimental animal models of diabetic neuropathy. Diabetologia. 1987, 30: 653-658.","journal-title":"Diabetologia"},{"key":"162_CR100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.peptides.2010.09.029","volume":"32","author":"M Ohsawa","year":"2011","unstructured":"Ohsawa M, Carlsson A, Asato M, Koizumi T, Nakanishi Y, Fransson R, Sandstrom A, Hallberg M, Nyberg F, Kamei J: The effect of substance P1-7 amide on nociceptive threshold in diabetic mice. Peptides. 2011, 32: 93-98.","journal-title":"Peptides"},{"key":"162_CR101","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.expneurol.2004.11.001","volume":"192","author":"SB McMahon","year":"2005","unstructured":"McMahon SB, Cafferty WB, Marchand F: Immune and glial cell factors as pain mediators and modulators. Exp Neurol. 2005, 192: 444-462.","journal-title":"Exp Neurol"},{"key":"162_CR102","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1523\/JNEUROSCI.4476-07.2008","volume":"28","author":"CE Constantin","year":"2008","unstructured":"Constantin CE, Mair N, Sailer CA, Andratsch M, Xu ZZ, Blumer MJ, Scherbakov N, Davis JB, Bluethmann H, Ji RR, Kress M: Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. J Neurosci. 2008, 28: 5072-5081.","journal-title":"J Neurosci"},{"key":"162_CR103","doi-asserted-by":"crossref","first-page":"14062","DOI":"10.1523\/JNEUROSCI.3795-08.2008","volume":"28","author":"AM Binshtok","year":"2008","unstructured":"Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR, Bean BP, Woolf CJ, Samad TA: Nociceptors are interleukin-1beta sensors. J Neurosci. 2008, 28: 14062-14073.","journal-title":"J Neurosci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-014-0162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12974-014-0162-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-014-0162-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-014-0162-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T01:36:29Z","timestamp":1650159389000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-014-0162-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,16]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1186\/s12974-014-0162-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,16]]},"assertion":[{"value":"18 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"162"}}